ME Therapeutics Holdings Inc. (CSE:METX)
1.750
-2.350 (-57.32%)
At close: Sep 18, 2026
| Market Cap | 53.18M -64.1% |
| Revenue (ttm) | n/a |
| Net Income | -1.38M |
| EPS | -0.05 |
| Shares Out | 30.39M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,200 |
| Open | 2.800 |
| Previous Close | 4.100 |
| Day's Range | 1.750 - 2.800 |
| 52-Week Range | 0.790 - 8.000 |
| Beta | -0.04 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 27, 2026 |